Aspect Biosystems Website, Blog & Press Pages

Aspect Biosystems Website, Blog & Press Pages - aVenture

Aspect Biosystems - Library

aspectbiosystems.comCrawled Oct 16, 2026

Product

1 page

Full-Stack Tissue Therapeutic Platform/technology
The company combines AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to create allogeneic tissue therapeutics.

Blog

3 pages

[UBC Webinar]: From Life to Lab: Translation of Regenerative Medicine Therapies and Technologies/news-resources/ubc-webinar-translation-of-regenerative-medicine-therapies-and-technologies
Aspect CSO Sam Wadsworth presented
Aspect Hosting Virtual Panel on Advancing Tissue Therapeutics to the Clinic/news-resources/webinar-advancing-tissue-therapeutics-to-the-clinic-2020-07-29
The page promotes a panel discussion on biomaterial sourcing, cell manufacturing, and regulatory strategies for developing tissue therapeutics.
Women in biotech panel discussion - Feb 11, 2022/news-resources/webinar-women-in-biotech-panel-discussion-2022
The page promotes a virtual panel discussion featuring Canadian women in biotech for the International Day of Women & Girls in Science.

Press

6 pages

Aspect Biosystems and JSR Corporation Enter Collaboration to Develop Bioprinted Vascularized Tissues for Regenerative Medicine/news-resources/aspect-biosystems-announces-jsr-collaboration-bioprinted-vascularized-tissues
Aspect Biosystems announces a new joint development program with JSR Corporation to develop implantable vascularized tissues for kidney regeneration and other applications in regenerative medicine.
Aspect Biosystems Enters Collaboration with UHN to Secure Access to Stem Cell-Derived Hepatocytes for Bioprinted Liver Therapeutics/news-resources/enters-collaboration-with-uhn-to-secure-access-to-stem-cell-derived-hepatocytes-for-bioprinted-therapeutics
Aspect Biosystems is collaborating with the McEwen Stem Cell Institute at the University Health Network to combine bioprinting technology with stem cell differentiation protocols to develop bioprinted cell therapies for genetic and acquired liver diseases.
Aspect Biosystems Named to Fast Company’s 2023 List of the Next Big Things in Tech/news-resources/aspect-biosystems-named-to-fast-company-2023-list-of-the-next-big-things-in-tech
Aspect Biosystems today announced that it has been named to Fast Company’s third annual Next Big Things in Tech list, honoring technological breakthroughs that promise to shape the future of industries.
Aspect Biosystems Receives Over $3.6 Million from the Government of Canada/news-resources/aspect-biosystems-receives-over-3-6-million-from-the-government-of-canada
This investment from the Pacific Economic Development Agency of Canada will help broaden the application of Aspect’s bioprinting technology for therapeutic development, expand its global network of partners, and scale-up its manufacturing systems

Careers & Hiring

6 pages

[HIRING]: Microfluidics manufacturing technician/careers/microfluidics-manufacturing-technician
The company seeks a microfluidics manufacturing technician to assemble 3D microfluidic printheads and custom manufacturing equipment.
[HIRING]: Process development associate/careers/process-development-associate
The company seeks a process development associate to support cGMP production of its bioprinted therapeutics, with a focus on bioprocessing and GMP manufacturing.
[HIRING]: Research engineer/careers/research-engineer-1
Aspect seeks a research engineer for its preclinical research and development team to advance bioprinted tissue therapeutics and address challenges in mechanical, chemical, and tissue engineering.
[HIRING]: Research scientist, pancreas tissue engineering/careers/research-scientist-pancreas-tissue-engineering
The company seeks a research scientist to help advance its therapeutic portfolio from discovery to clinical manufacturing, with responsibility for designing and developing a 3D bioprinted pancreas tissue therapeutic.

About

1 page

Our Story/about

Contact

1 page

Get in Touch/contact

Homepage

1 page

Homepage/
The company develops bioprinted tissue therapeutics.

Privacy

1 page